Subtype-Guided F-FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility Study.

Date publication

décembre 2019

Journal

The oncologist

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COCHET Alexandre

Tous les auteurs :
Wu S, Wang Y, Li J, Zhang N, Mo M, Klimberg S, Kaklamani V, Cochet A, Shao Z, Cheng J, Liu G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31826976

Résumé

The purpose of this study was to investigate the value of [F]-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) in tailoring axillary surgery by predicting nodal response among patients with node-positive breast cancer after neoadjuvant chemotherapy (NAC).

Mots clés

18[F]‐fluorodeoxyglucose positron emission tomography/computed tomography, Axillary surgery, Neoadjuvant chemotherapy, Response, Subtype‐guided

Référence

Oncologist. 2019 Dec 11;: